← Leaderboards
Charles J Dimitroff
Brigham And Women'S Hospital
$9,730,798
Attributed
$9,842,769
Total exposure
12
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $697.7K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,842,769 · 12
By mechanism
R01$5,860,120 · 4
U01$2,359,852 · 1
R21$1,490,913 · 4
F32$86,388 · 1
P30$45,496 · 2
Top collaborators
- Stuart Haslam1 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Jeffrey Sklar$6,561,305
- Daniel Hal Solomon$26,002,677
- Bruce H Horwitz$3,653,470
- Jonathan Li$17,759,976
- Rachael Ann Clark$20,922,246
Others in their field
Top investigators on “Ligands”
- John Damon Chodera · Sloan-Kettering Inst Can Research$39,009,297
- Keith W Miller · Massachusetts General Hospital$35,506,092
- Ian A Wilson · Scripps Research Institute, The$35,392,112
- Bryan L Roth · Univ Of North Carolina Chapel Hill$32,442,555
- Edward Franklin Plow · Cleveland Clinic Foundation$32,215,714
- Helen M Berman · Rutgers University New Brunswick$32,076,400
Research focus
LigandsPolysaccharidesStructureInsightLaboratoriesGlycosyltransferaseAdhesionsCellsInnovationGrantIn VivoLectinMediatingRegulationMalignant - DescriptorReceptorNeoplasm MetastasisCell AdhesionTissuesMalignant NeoplasmsGrowthCell SurfaceInvestigationBehavior
Grant awards (34)
Analysis of galectin-8 and its ligands in melanoma progression$538,782
R01 · FY2025 · CA · contact PI
Analysis of galectin-8 and its ligands in melanoma progression$475,743
R01 · FY2024 · CA · contact PI
Analysis of Glycomic Regulators in Melanoma Progression$476,319
U01 · FY2023 · CA · contact PI
Analysis of Glycomic Regulators in Melanoma Progression$476,815
U01 · FY2022 · CA · contact PI
Analysis of Glycomic Regulators in Melanoma Progression$487,029
U01 · FY2021 · CA · contact PI
Analysis of Glycomic Regulators in Melanoma Progression$414,427
U01 · FY2020 · CA · contact PI
Analysis of vascular Galectin-9 as an immunomodulator of B-cell activity$204,670
R21 · FY2020 · AI · contact PI
Analysis of Glycomic Regulators in Melanoma Progression$281,320
U01 · FY2019 · CA · contact PI
Analysis of Glycomic Regulators in Melanoma Progression$223,942
U01 · FY2019 · CA · contact PI
Analysis of vascular Galectin-9 as an immunomodulator of B-cell activity$179,670
R21 · FY2019 · AI · contact PI
Functional Analysis of Galectin-1 Ligands in Melanoma Progression$361,558
R01 · FY2017 · CA · contact PI
Glycomic Characterization of Germinal Center B cells$241,450
R21 · FY2017 · AI · contact PI
Functional Analysis of Galectin-1 Ligands in Melanoma Progression$361,558
R01 · FY2016 · CA · contact PI
Glycomic Characterization of Germinal Center B cells$209,475
R21 · FY2016 · AI · contact PI
Functional Analysis of Galectin-1 Ligands in Melanoma Progression$361,144
R01 · FY2015 · CA · contact PI
Functional Analysis of Galectin-1 Ligands in Melanoma Progression$349,346
R01 · FY2014 · CA · contact PI
Functional Analysis of Galectin-1 Ligands in Melanoma Progression$359,321
R01 · FY2013 · CA · contact PI
Mechanistic Analysis of Anti-inflammatory Activity by Fluorosugars$410,850
R01 · FY2012 · AT · contact PI
Mechanistic Analysis of Anti-inflammatory Activity by Fluorosugars$410,850
R01 · FY2011 · AT · contact PI
Analysis of Homing Receptors in Prostate Cancer$274,238
R01 · FY2011 · CA · contact PI
Mechanistic Analysis of Anti-inflammatory Activity by Fluorosugars$410,850
R01 · FY2010 · AT · contact PI
Analysis of Homing Receptors in Prostate Cancer$282,720
R01 · FY2010 · CA · contact PI
Mechanistic Analysis of Anti-inflammatory Activity by Fluorosugars$415,000
R01 · FY2009 · AT · contact PI
Analysis of Homing Receptors in Prostate Cancer$282,720
R01 · FY2009 · CA · contact PI
Analysis of Homing Receptors in Prostate Cancer$282,720
R01 · FY2008 · CA · contact PI
Allergic Contact Dermatitis Skin-Homing Receptors on Natural Killer Cells$45,496
P30 · FY2008 · AR · contact PI
Analysis of Homing Receptors in Prostate Cancer$282,720
R01 · FY2007 · CA · contact PI
CLA as a Mediator of Human Prostate Tumor Metastasis$154,824
R21 · FY2005 · CA
Bone-Homing Molecules on Human Prostate Tumor Cells$173,000
R21 · FY2004 · CA
CLA as a Mediator of Human Prostate Tumor Metastasis$154,824
R21 · FY2004 · CA
Bone-Homing Molecules on Human Prostate Tumor Cells$173,000
R21 · FY2003 · CA
Identity and Structural Biology of CLA in Leukemias$46,192
F32 · FY2002 · CA
Therapeutic inhibition of leukocyte migration to skin$0
P30 · FY2002 · AR
Identity and Structural Biology of CLA in Leukemias$40,196
F32 · FY2001 · CA